TipRanks
Go Ultimate55% OFF

Trevena (TRVN) Stock Price & Analysis

TRVN Stock Chart & Stats

$0.01$0.00(0.00%)
At close: 4:00 PM EDT
$0.02$0.04$0.0617 Sep29 Sep5 Oct12 Oct26 Oct
Day’s Range
$0.01 - $0.01
52-Week Range
$0.01 - $0.07
Previous Close
$0.01
Volume
N/A
Average Volume (3M)
200
Market Cap
$9,588
Enterprise Value
$27.01M
Total Cash (Recent Filing)
$13.46M
Total Debt (Recent Filing)
$37.56M
Price to Earnings (P/E)
―
Beta
-10.05
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Product Portfolio

OLINVYK's FDA approval for acute pain management provides a strong foundation for Trevena's product portfolio, supporting long-term revenue potential in the pain management sector.

Strategic Partnerships

Strategic partnerships and licensing agreements enhance Trevena's ability to expand its market reach and leverage external expertise, contributing to sustainable growth.

Leadership Stability

The appointment of Katrine Sutton as CFO, with her extensive industry experience, is expected to strengthen financial management and strategic decision-making, supporting long-term stability.

Bears Say

Financial Health

Trevena's negative equity and ongoing losses highlight severe financial instability, posing significant long-term risks to its operational sustainability and ability to invest in growth.

Revenue Decline

The sharp decline in revenue growth indicates weakening market demand or competitive pressures, challenging Trevena's ability to maintain its market position and grow its business.

Cash Flow Issues

Deteriorating cash flow generation limits Trevena's financial flexibility, impacting its capacity to fund operations, invest in R&D, and manage debt, threatening long-term viability.

Trevena News

TRVN FAQ

What was Trevena’s price range in the past 12 months?
Trevena lowest stock price was $0.01 and its highest was $0.07 in the past 12 months.
What is Trevena’s market cap?
Trevena’s market cap is $9,588.
When is Trevena’s upcoming earnings report date?
Trevena’s next earnings report is estimated for Mar 13, 2025 (not yet confirmed), which is 600 days ago.
How were Trevena’s earnings last quarter?
Trevena released its earnings results on Nov 07, 2024. The company reported -$5.79 earnings per share for the quarter, beating the consensus estimate of -$7.75 by $1.96.
Is Trevena overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Trevena pay dividends?
Trevena does not currently pay dividends.
What is Trevena’s EPS estimate?
Trevena’s EPS estimate is -2.50.
How many shares outstanding does Trevena have?
Trevena has 863,788 shares outstanding.
What happened to Trevena’s price movement after its last earnings report?
Trevena reported an EPS of -$5.79 in its last earnings report, beating expectations of -$7.75. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Trevena?
Hedge funds hold Trevena shares: the largest hedge-fund position in Trevena is 71,857,081 shares, and hedge funds decreased their holdings by 5.3K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology